Application Nr Approved Date Route Status External Links
NDA204708 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mirvaso (Brimonidine) Topical Gel, 0.33% Is An Alpha Adrenergic Agonist Indicated For The Topical Treatment Of Persistent (Nontransient) Erythema Of Rosacea In Adults 18 Years Of Age Or Older. Mirvaso (Brimonidine) Topical Gel, 0.33% Is An Alpha Adrenergic Agonist Indicated For The Topical Treatment Of Persistent (Nontransient) Facial Erythema Of Rosacea In Adults 18 Years Of Age Or Older.( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Brimonidine Tartrate BRIMONIDINE TARTRATE ZINC895301

Comments